BIOMAT Database Logo BIOMAT Database Logo

[Pharmacokinetics and relative biological availability of karfecillin Spofa (author's transl)]. 1978

K Dvorácek, and I Jankau, and V Krebs, and Z Modr

UI MeSH Term Description Entries
D002228 Carbenicillin Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function. Carboxybenzyl Penicillin,Anabactyl,Carbapen,Carbecin,Carbenicillin Disodium,Geopen,Microcillin,Pyopen,Disodium, Carbenicillin,Penicillin, Carboxybenzyl
D002323 Carfecillin The phenyl ester of CARBENICILLIN that, upon oral administration, is broken down in the intestinal mucosa to the active antibacterial. It is used for urinary tract infections. Carbenicillin Phenyl Sodium,BRL-3475,Carfecillin Sodium Salt,Carphecillin,Uticillin,BRL 3475,BRL3475,Salt, Carfecillin Sodium,Sodium Salt, Carfecillin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Clomifen Spofa (author's transl)].
March 1974, Casopis lekaru ceskych,
K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Pharmacokinetics of tribuzone (Benetazone Spofa) in patients with Gilbert's syndrome (author's transl)].
October 1980, Ceskoslovenska gastroenterologie a vyziva,
K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Biological availability of two theophylline preparations (author's transl)].
June 1982, Praxis und Klinik der Pneumologie,
K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
January 1980, Arzneimittel-Forschung,
K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Antilysin Spofa--original Czechoslovak proteinase inhibitor (author's transl)].
July 1974, Casopis lekaru ceskych,
K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Biological availability of calcium from 45ca-labelled eggshells (author's transl)].
March 1978, Bratislavske lekarske listy,
K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Effectiveness of fenalgin SPOFA in lumboischiadic syndrome (author's transl)].
April 1979, Bratislavske lekarske listy,
K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Application of soft contact lenses Spofa-lens (author's transl)].
February 1977, Klinika oczna,
K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Sulfamethoxydin Spofa in the treatment of adnexitis (author's transl)].
September 1973, Ceskoslovenska gynekologie,
K Dvorácek, and I Jankau, and V Krebs, and Z Modr
[Biological availability of spironolactone in two different galenic forms (author's transl)].
June 1979, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!